PropThink: Titan Files NDA on Probuphine; Partner Waits

Published November 21, 2012

PropThink: Titan Files NDA on Probuphine; Partner Waits

Filed under: drug treatment news 2012

By Jason Napodano, CFA. Monday morning, Titan Pharmaceuticals (OTC:TTNP) announced it had filed a New Drug Application (NDA) to the U.S. FDA on Probuphine for the maintenance treatment of opioid dependence in adults patients (Press Release). … In …
Read more on Reuters

Pluristem Reports Status of Orphan Drug Application for Aplastic Anemia

Filed under: drug treatment news 2012

21, 2012 (GLOBE NEWSWIRE) — Pluristem Therapeutics, Inc. (Nasdaq:PSTI) (TASE:PLTR), a leading developer of placenta-based cell therapies, today announced that the U.S. Food and Drug Administration (FDA) has updated the Company on its application to …
Read more on Equities.com

Report urges move away from prescription drugs to treat chronic pain

Filed under: drug treatment news 2012

A new medical report highlights how Vermont's health care system financially encourages a patient's dependence on opioids, instead of other more effective and less addictive remedies. The report, which was authored by Dr. Cyrus Jordan of the Vermont …
Read more on vtdigger.org